1. Improved Differentiation of Pancreatic Tumors Using Contrast-Enhanced Endoscopic Ultrasound 
Christoph F. Dietrich, Andre Ignee, Barbara Braden, Ana Paula Barreiros, Michaela Ott, Michael Hocke 
Clinical Gastroenterology and Hepatology 
Volume 6, Issue 5, Pages e1 (May 2008)
DOI: /j.cgh
Copyright © 2008 AGA Institute Terms and Conditions

2. Figure 1
CE-EDUS in a patient with hypovascular ductal adenocarcinoma of the pancreas. (A) CDI and (B) contrast-enhanced Doppler ultrasound both revealed a hypovascular lesion.
Clinical Gastroenterology and Hepatology 2008 6, e1DOI: ( /j.cgh )
Copyright © 2008 AGA Institute Terms and Conditions

3. Figure 2
CE-EDUS in a patient with a hypervascular neuroendocrine tumor. (A) CDI and (B) contrast-enhanced Doppler ultrasound both showed a hypervascular lesion.
Clinical Gastroenterology and Hepatology 2008 6, e1DOI: ( /j.cgh )
Copyright © 2008 AGA Institute Terms and Conditions

4. Figure 3
CE-EDUS in a patient with a hypervascular serous microcystic adenoma of the pancreas. (A) CDI was not conclusive but (B–D) contrast-enhanced Doppler ultrasound revealed definite hypervascularity. In the initial arterial phase stimulated acoustic emission might be misleading. (E and F) Nonvascularized lesions also can be displayed using this method shown in a patient with thrombosed pseudoaneurysm. Note the avascular parts of thrombosis.
Clinical Gastroenterology and Hepatology 2008 6, e1DOI: ( /j.cgh )
Copyright © 2008 AGA Institute Terms and Conditions